Cargando…
High-Dose Chemotherapy with Autologous Hematopoietic Stem-Cell Rescue for Pediatric Brain Tumor Patients: A Single Institution Experience from UCLA
Background. Dose-dependent response makes certain pediatric brain tumors appropriate targets for high-dose chemotherapy with autologous hematopoietic stem-cell rescue (HDCT-AHSCR). Methods. The clinical outcomes and toxicities were analyzed retrospectively for 18 consecutive patients ≤19 y/o treated...
Autores principales: | Panosyan, Eduard H., Ikeda, Alan K., Chang, Vivian Y., Laks, Dan R., Reeb, Charles L., Bowles, La Vette, Lasky, Joseph L., Moore, Theodore B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087896/ https://www.ncbi.nlm.nih.gov/pubmed/21559259 http://dx.doi.org/10.1155/2011/740673 |
Ejemplares similares
-
Treatment of atypical central neurocytoma in a child with high dose chemotherapy and autologous stem cell rescue
por: Buchbinder, David, et al.
Publicado: (2009) -
UCLA Dark Matter Advanced Training Institute 2018
Publicado: (2018) -
An American contribution to neuroscience: the Brain Research Institute, UCLA, 1959—1984
por: Clarke, Edwin
Publicado: (1986) -
In search of druggable targets for GBM amino acid metabolism
por: Panosyan, Eduard H., et al.
Publicado: (2017) -
The UCLA SMP system
por: Slater, W E
Publicado: (1970)